Hedge Fund - Legion Partners Asset Management
Lifecore Biomedical Inc. (LFCR)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $31,200,034 | 20.71% | 4,431,823 | $6.21 |
| 2 | 2024 - Q4 (2024-12-31) | $32,928,445 | 19.2% | 4,431,823 | $6.39 |
| 3 | 2024 - Q3 (2024-09-30) | $14,634,256 | 5.07% | 2,968,409 | $5.22 |
| 4 | 2024 - Q2 (2024-06-30) | $15,227,938 | 4.69% | 2,968,409 | $5.92 |
| 5 | 2024 - Q1 (2024-03-31) | $15,665,705 | 3.62% | 2,950,227 | $7.15 |
| 6 | 2023 - Q4 (2023-12-31) | $18,200,705 | 4.74% | 2,940,340 | $6.94 |
| 7 | 2023 - Q3 (2023-09-30) | $22,184,865 | 6.66% | 2,940,340 | $9.14 |
| 8 | 2023 - Q2 (2023-06-30) | $28,433,088 | 8.31% | 2,940,340 | $6.11 |
| 9 | 2023 - Q1 (2023-03-31) | $11,114,485 | 3.26% | 2,940,340 | $5.57 |
| 10 | 2022 - Q4 (2022-12-31) | $19,053,403 | 5.83% | 2,940,340 | $8.24 |
| 11 | 2022 - Q3 (2022-09-30) | $26,140,000 | 9.43% | 2,940,340 | $10.17 |
| 12 | 2022 - Q2 (2022-06-30) | $29,315,000 | 7.61% | 2,940,340 | $9.90 |
| 13 | 2022 - Q1 (2022-03-31) | $34,049,000 | 6.24% | 2,940,340 | $11.14 |
| 14 | 2021 - Q4 (2021-12-31) | $32,502,000 | 6.08% | 2,928,090 | $9.70 |
| 15 | 2021 - Q3 (2021-09-30) | $26,997,000 | 5.55% | 2,928,090 | $10.88 |
| 16 | 2021 - Q2 (2021-06-30) | $32,941,000 | 6.61% | 2,928,090 | $11.53 |
| 17 | 2021 - Q1 (2021-03-31) | $31,038,000 | 6.21% | 2,928,090 | $11.24 |
| 18 | 2020 - Q4 (2020-12-31) | $31,512,000 | 8.19% | 2,904,340 | $10.33 |
| 19 | 2020 - Q3 (2020-09-30) | $28,230,000 | 6.75% | 2,904,340 | $9.52 |
| 20 | 2020 - Q2 (2020-06-30) | $23,119,000 | 6.47% | 2,904,340 | $10.32 |
| 21 | 2020 - Q1 (2020-03-31) | $20,695,000 | 8.72% | 2,381,493 | $10.41 |
| 22 | 2019 - Q4 (2019-12-31) | $13,302,000 | 3.44% | 1,176,105 | $10.64 |
| 23 | 2019 - Q3 (2019-09-30) | $6,629,000 | 1.62% | 609,860 | $10.89 |
The displayed share prices are average quarterly stock market prices.